1887

Abstract

Porcine endogenous retroviruses (PERVs) are present in the genomes of pig cells. The PERV-A/C recombinant virus can infect human cells and is a major risk of zoonotic disease in the case of xenotransplantation of pig organs to humans. Raltegravir (RAL) is a viral integrase (IN) inhibitor used in highly active antiretroviral treatment. In the present study, we explored the potential use of RAL against PERV-A/C. We report (i) a three-dimensional model of the PERV-A/C intasome complexed with RAL, (ii) the sensitivity of PERV-A/C IN to RAL and (iii) the sensitivity of a PERV-A/C-IRES-GFP recombinant virus to RAL . We demonstrated that RAL is a potent inhibitor against PERV-A/C IN and PERV-A/C replication with ICs in the nanomolar range. To date, the use of retroviral inhibitors remains the only way to control the risk of zoonotic PERV infection during pig-to-human xenotransplantation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000236
2015-10-01
2020-04-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/10/3124.html?itemId=/content/journal/jgv/10.1099/jgv.0.000236&mimeType=html&fmt=ahah

References

  1. Arnold K., Bordoli L., Kopp J., Schwede T. 2006; The swiss-model workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201 [CrossRef][PubMed]
    [Google Scholar]
  2. Bar-Magen T., Sloan R.D., Faltenbacher V.H., Donahue D.A., Kuhl B.D., Oliveira M., Xu H., Wainberg M.A. 2009; Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes. Retrovirology 6:103 [CrossRef][PubMed]
    [Google Scholar]
  3. Bartosch B., Stefanidis D., Myers R., Weiss R., Patience C., Takeuchi Y. 2004; Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 78:13880–13890 [CrossRef][PubMed]
    [Google Scholar]
  4. Cellier C., Moreau K., Gallay K., Ballandras A., Gouet P., Ronfort C. 2013; In vitro functional analyses of the human immunodeficiency virus type 1 (HIV-1) integrase mutants give new insights into the intasome assembly. Virology 439:97–104 [CrossRef][PubMed]
    [Google Scholar]
  5. Charmetant J., Moreau K., Gallay K., Ballandras A., Gouet P., Ronfort C. 2011; Functional analyses of mutants of the central core domain of an Avian Sarcoma/Leukemia Virus integrase. Virology 421:42–50 [CrossRef][PubMed]
    [Google Scholar]
  6. DeAnda F., Hightower K.E., Nolte R.T., Hattori K., Yoshinaga T., Kawasuji T., Underwood M.R. 2013; Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics. PLoS One 8:e77448 [CrossRef][PubMed]
    [Google Scholar]
  7. DeLano W.L. 2008 The PyMol Molecular Graphics Systems Palo Alto, CA: DeLano Scientific;
    [Google Scholar]
  8. Emsley P., Lohkamp B., Scott W.G., Cowtan K. 2010; Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486–501 [CrossRef][PubMed]
    [Google Scholar]
  9. Engelman A. 2010; Reverse transcription and integration. In Retroviruses: Molecular Biology, Genomics and Pathogenesis pp. 129–159 Edited by Kurth R., Bannert N. Norfolk: Caister Academic Press;
    [Google Scholar]
  10. Gouet P., Robert X., Courcelle E. 2003; ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res 31:3320–3323 [CrossRef][PubMed]
    [Google Scholar]
  11. Groenen M.A., Archibald A.L., Uenishi H., Tuggle C.K., Takeuchi Y., Rothschild M.F., Rogel-Gaillard C., Park C., Milan D., other authors. 2012; Analyses of pig genomes provide insight into porcine demography and evolution. Nature 491:393–398 [CrossRef][PubMed]
    [Google Scholar]
  12. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., other authors. 2003; LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419 [CrossRef][PubMed]
    [Google Scholar]
  13. Hare S., Gupta S.S., Valkov E., Engelman A., Cherepanov P. 2010a; Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464:232–236 [CrossRef][PubMed]
    [Google Scholar]
  14. Hare S., Vos A.M., Clayton R.F., Thuring J.W., Cummings M.D., Cherepanov P. 2010b; Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc Natl Acad Sci U S A 107:20057–20062 [CrossRef][PubMed]
    [Google Scholar]
  15. Holm L., Kaariainen S., Wilton C., Plewczynski D. 2006; Using Dali for structural comparison of proteins. Curr Protoc Bioinformatics 14:5.5.1–5.5.24
    [Google Scholar]
  16. Jaskolski M., Alexandratos J.N., Bujacz G., Wlodawer A. 2009; Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J 276:2926–2946 [CrossRef][PubMed]
    [Google Scholar]
  17. Jonsson C.B., Donzella G.A., Roth M.J. 1993; Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli . J Biol Chem 268:1462–1469
    [Google Scholar]
  18. Kimsa M.C., Strzalka-Mrozik B., Kimsa M.W., Gola J., Nicholson P., Lopata K., Mazurek U. 2014; Porcine endogenous retroviruses in xenotransplantation – molecular aspects. Viruses 6:2062–2083 [CrossRef][PubMed]
    [Google Scholar]
  19. Koh Y., Matreyek K.A., Engelman A. 2011; Differential sensitivities of retroviruses to integrase strand transfer inhibitors. J Virol 85:3677–3682 [CrossRef][PubMed]
    [Google Scholar]
  20. Krishnan L, Li X., Naraharisetty H.L., Hare S., Cherepanov P., Engelman A. 2010; Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proceedings of the National Academy of Sciences of the United States of America 107:15910–15915 [CrossRef]
    [Google Scholar]
  21. Kvaratskhelia M., Sharma A., Larue R.C., Serrao E., Engelman A. 2014; Molecular mechanisms of retroviral integration site selection. Nucleic Acids Res 42:10209–10225 [CrossRef][PubMed]
    [Google Scholar]
  22. Maertens G.N., Hare S., Cherepanov P. 2010; The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468:326–329 [CrossRef][PubMed]
    [Google Scholar]
  23. Martin S.I., Wilkinson R., Fishman J.A. 2006; Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol J 3:91 [CrossRef][PubMed]
    [Google Scholar]
  24. Mitchell R.S., Beitzel B.F., Schroder A.R., Shinn P., Chen H., Berry C.C., Ecker J.R., Bushman F.D. 2004; Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2:E234 [CrossRef][PubMed]
    [Google Scholar]
  25. Moalic Y., Blanchard Y., Félix H., Jestin A. 2006; Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J Virol 80:10980–10988 [CrossRef][PubMed]
    [Google Scholar]
  26. Moalic Y., Félix H., Takeuchi Y., Jestin A., Blanchard Y. 2009; Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots. J Virol 83:1920–1929 [CrossRef][PubMed]
    [Google Scholar]
  27. Moreau K., Faure C., Verdier G., Ronfort C. 2002; Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro . Arch Virol 147:1761–1778 [CrossRef][PubMed]
    [Google Scholar]
  28. Moreau K., Faure C., Violot S., Verdier G., Ronfort C. 2003; Mutations in the C-terminal domain of ALSV (Avian Leukemia and Sarcoma Viruses) integrase alter the concerted DNA integration process in vitro . Eur J Biochem 270:4426–4438 [CrossRef][PubMed]
    [Google Scholar]
  29. Moreau K., Faure C., Violot S., Gouet P., Verdier G., Ronfort C. 2004; Mutational analyses of the core domain of Avian Leukemia and Sarcoma Viruses integrase: critical residues for concerted integration and multimerization. Virology 318:566–581 [CrossRef][PubMed]
    [Google Scholar]
  30. Moreau K., Charmetant J., Gallay K., Faure C., Verdier G., Ronfort C. 2009; Avian sarcoma and leukemia virus (ASLV) integration in vitro: mutation or deletion of integrase (IN) recognition sequences does not prevent but only reduces the efficiency and accuracy of DNA integration. Virology 392:94–102 [CrossRef][PubMed]
    [Google Scholar]
  31. Nowrouzi A., Dittrich M., Klanke C., Heinkelein M., Rammling M., Dandekar T., von Kalle C., Rethwilm A. 2006; Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol 87:1339–1347 [CrossRef][PubMed]
    [Google Scholar]
  32. Patience C., Takeuchi Y., Weiss R.A. 1997; Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282–286 [CrossRef][PubMed]
    [Google Scholar]
  33. Qari S.H., Magre S., García-Lerma J.G., Hussain A.I., Takeuchi Y., Patience C., Weiss R.A., Heneine W. 2001; Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J Virol 75:1048–1053 [CrossRef][PubMed]
    [Google Scholar]
  34. Raffi F., Jaeger H., Quiros-Roldan E., Albrecht H., Belonosova E., Gatell J.M., Baril J.G., Domingo P., Brennan C., other authors. 2013; Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis 13:927–935 [CrossRef][PubMed]
    [Google Scholar]
  35. Réty S., Reaeábková L., Dubanchet B., Silhán J., Legrand P., Lewit-Bentley A. 2010; Structural studies of the catalytic core of the primate foamy virus (PFV-1) integrase. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:881–886 [CrossRef][PubMed]
    [Google Scholar]
  36. Serrao E., Odde S., Ramkumar K., Neamati N. 2009; Raltegravir, elvitegravir, and metoogravir: the birth of “me-too” HIV-1 integrase inhibitors. Retrovirology 6:25 [CrossRef][PubMed]
    [Google Scholar]
  37. Stephan O., Schwendemann J., Specke V., Tacke S.J., Boller K., Denner J. 2001; Porcine endogenous retroviruses (PERVs): generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT. Xenotransplantation 8:310–316 [CrossRef][PubMed]
    [Google Scholar]
  38. Trabaud M.A., Cotte L., Saison J., Ramière C., Ronfort C., Venet F., Tardy J.C., Monneret G., André P. 2015; Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient. AIDS Res Hum Retroviruses 31:142–149 [CrossRef][PubMed]
    [Google Scholar]
  39. Trobridge G.D., Miller D.G., Jacobs M.A., Allen J.M., Kiem H.P., Kaul R., Russell D.W. 2006; Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci U S A 103:1498–1503 [CrossRef][PubMed]
    [Google Scholar]
  40. Vagin A.A., Steiner R.A., Lebedev A.A., Potterton L., McNicholas S., Long F., Murshudov G.N. 2004; refmac5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr 60:2184–2195 [CrossRef][PubMed]
    [Google Scholar]
  41. Wilhelm M., Fishman J.A., Pontikis R., Aubertin A.M., Wilhelm F.X. 2002; Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors. Cell Mol Life Sci 59:2184–2190 [CrossRef][PubMed]
    [Google Scholar]
  42. Wood A., Webb B.L., Bartosch B., Schaller T., Takeuchi Y., Towers G.J. 2009; Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol 90:702–709 [CrossRef][PubMed]
    [Google Scholar]
  43. Yang F., Leon O., Greenfield N.J., Roth M.J. 1999; Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization. J Virol 73:1809–1817
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000236
Loading
/content/journal/jgv/10.1099/jgv.0.000236
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error